Mannkind (MNKD) Change in Cash (2010 - 2026)
Mannkind (MNKD) reported Change in Cash of -$22.0 million for Q1 2026, down 2361.13% year-over-year from $975000.0 in Q1 2025, and up 58.01% on a QoQ basis from -$52.5 million in Q4 2025.
Mannkind (MNKD) has 17 years of Change in Cash data on file, last reported at -$22.0 million in Q1 2026.
- Quarterly Change in Cash fell 2361.13% year-over-year to -$22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 103.81% YoY) and the FY2025 annual result came in at $28.6 million, up 114.92% from the prior year.
- Change in Cash climbed to -$22.0 million in Q1 2026 per MNKD's latest filing, from -$52.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $155.5 million in Q4 2023 and bottomed at -$95.9 million in Q2 2024.
- The 5-year median for Change in Cash is -$3.2 million (2023), against an average of -$4.2 million.
- The widest annual swing landed in 2023, when Change in Cash soared 905.65%; it then slumped 30543.49% in 2024.
- Tracing MNKD's Change in Cash over 5 years: stood at $15.5 million in 2022, then soared by 905.65% to $155.5 million in 2023, then plunged by 110.31% to -$16.0 million in 2024, then plunged by 227.52% to -$52.5 million in 2025, then surged by 58.01% to -$22.0 million in 2026.
- Per Business Quant, the three latest MNKD Change in Cash figures stand at -$22.0 million (Q1 2026), -$52.5 million (Q4 2025), and $70.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -22.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.05 Mn |
| Dec 31, 2025 | -52.51 Mn |
| Sep 30, 2025 | 70.39 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 975,000.00 |
| Dec 31, 2024 | -16.03 Mn |
| Sep 30, 2024 | -34.27 Mn |
| Jun 30, 2024 | -95.90 Mn |
| Mar 31, 2024 | -45.21 Mn |
| Dec 31, 2023 | 155.46 Mn |
| Sep 30, 2023 | -3.17 Mn |
| Jun 30, 2023 | 315,000.00 |
| Mar 31, 2023 | 16.10 Mn |
| Dec 31, 2022 | 15.46 Mn |
| Sep 30, 2022 | 18.80 Mn |
| Jun 30, 2022 | -31.74 Mn |
| Mar 31, 2022 | -56.94 Mn |
| Dec 31, 2021 | 72.44 Mn |
| Sep 30, 2021 | -10.78 Mn |
| Jun 30, 2021 | -185.47 Mn |
| Mar 31, 2021 | 180.83 Mn |
| Dec 31, 2020 | 14.45 Mn |
| Sep 30, 2020 | -10.82 Mn |
| Jun 30, 2020 | 24.35 Mn |
| Mar 31, 2020 | 8.96 Mn |
| Dec 31, 2019 | -267,000.00 |
| Sep 30, 2019 | 17.21 Mn |
| Jun 30, 2019 | -21.77 Mn |
| Mar 31, 2019 | -36.63 Mn |
| Dec 31, 2018 | 60.71 Mn |
| Sep 30, 2018 | -15.73 Mn |
| Jun 30, 2018 | -528,000.00 |
| Mar 31, 2018 | -21.12 Mn |
| Dec 31, 2017 | 28.26 Mn |
| Sep 30, 2017 | -23.29 Mn |
| Jun 30, 2017 | -4.59 Mn |
| Mar 31, 2017 | 25.08 Mn |
| Dec 31, 2016 | -12.64 Mn |
| Sep 30, 2016 | -28.20 Mn |
| Jun 30, 2016 | 36.08 Mn |
| Mar 31, 2016 | -31.42 Mn |
| Dec 31, 2015 | 26.15 Mn |
| Sep 30, 2015 | -74.26 Mn |
| Jun 30, 2015 | -13.66 Mn |
| Mar 31, 2015 | 3,000.00 |
| Dec 31, 2014 | -51.62 Mn |
| Sep 30, 2014 | 131.25 Mn |
| Jun 30, 2014 | 5.46 Mn |
| Mar 31, 2014 | -35.03 Mn |
| Dec 31, 2013 | -23.01 Mn |
| Sep 30, 2013 | 65.27 Mn |
| Jun 30, 2013 | 524,000.00 |
| Mar 31, 2013 | -33.84 Mn |
| Dec 31, 2012 | 60.08 Mn |
| Sep 30, 2012 | -29.87 Mn |
| Jun 30, 2012 | -24.72 Mn |
| Mar 31, 2012 | 53.67 Mn |
| Dec 31, 2011 | -20.11 Mn |
| Sep 30, 2011 | -1.98 Mn |
| Jun 30, 2011 | -22.14 Mn |
| Mar 31, 2011 | -19.15 Mn |
| Dec 31, 2010 | -31.87 Mn |
| Sep 30, 2010 | 69.57 Mn |